Commonwealth Equity Services’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,863
| Closed | -$38K | – | 2651 |
|
|
2017
Q2 | $38K | Sell |
3,863
-341
| -8% | -$3.35K | ﹤0.01% | 2436 |
|
|
2017
Q1 | $102K | Sell |
4,204
-267
| -6% | -$6.48K | ﹤0.01% | 2279 |
|
|
2016
Q4 | $144K | Sell |
4,471
-223
| -5% | -$7.18K | ﹤0.01% | 2144 |
|
|
2016
Q3 | $235K | Buy |
4,694
+445
| +10% | +$22.3K | ﹤0.01% | 1891 |
|
|
2016
Q2 | $180K | Sell |
4,249
-311
| -7% | -$13.2K | ﹤0.01% | 1996 |
|
|
2016
Q1 | $300K | Buy |
4,560
+84
| +2% | +$5.53K | ﹤0.01% | 1639 |
|
|
2015
Q4 | $278K | Buy |
4,476
+89
| +2% | +$5.53K | ﹤0.01% | 1656 |
|
|
2015
Q3 | $294K | Buy |
4,387
+883
| +25% | +$59.2K | ﹤0.01% | 1556 |
|
|
2015
Q2 | $341K | Buy |
3,504
+1,442
| +70% | +$140K | ﹤0.01% | 1560 |
|
|
2015
Q1 | $193K | Buy |
+2,062
| New | +$193K | ﹤0.01% | 1940 |
|